Literature DB >> 28102463

Marked Differences of Haplotype Tagging SNP Distribution, Linkage, and Haplotype Profile of APOA5 Gene in Roma Population Samples.

Katalin Sumegi1,2, Balazs Duga1,2, Bela I Melegh1,2, Zsolt Banfai1,2, Erzsebet Kovesdi1,2, Anita Maasz1, Bela Melegh3,4.   

Abstract

Roma people are underprivileged, neglected population worldwide, with severe healthcare problems. They have significantly increased prevalence of cardiovascular morbidity, presumably related to their poor social status, alcohol consumption and smoking habits. Assuming that genetic background also plays a role in their susceptibility for cardiovascular diseases, we hypothesized that APOA5 gene polymorphisms, an important role-player in lipid metabolism and in the development of metabolic syndrome and cardio/cerebrovascular events, may also be involved. We examined four APOA5 polymorphisms in 363 Roma and 404 Hungarian DNA samples. For rs662799, rs2266788, rs207560 and rs3135506 we found elevated plasma triglyceride levels in the risk allele carriers compared to non-carriers in both populations. At least a two-fold significant increase was detected in minor allele frequencies in Roma when compared to Hungarians, except the rs2266788 variant. Haplotype analysis revealed significant increase of APOA5*2, APOA5*4 in Roma, as opposed to the higher levels of APOA5*5 found in Hungarians. Different linkage disequilibrium was found between rs207560 and rs3135506 variants in Roma compared to Hungarians. The profound differences observed in almost all APOA5 polymorphisms in Roma require special attention, since these variants are known to associate with cardio/cerebrovascular susceptibility.

Entities:  

Keywords:  APOA5; Haplotype; Linkage disequilibrium; Roma; Triglyceride

Mesh:

Substances:

Year:  2017        PMID: 28102463     DOI: 10.1007/s12253-017-0197-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  49 in total

1.  The socio-economic determinants of the health status of Roma in comparison with non-Roma in Bulgaria, Hungary and Romania.

Authors:  Cristina Masseria; Philipa Mladovsky; Cristina Hernández-Quevedo
Journal:  Eur J Public Health       Date:  2010-07-22       Impact factor: 3.367

2.  Health status of Roma women in Spain.

Authors:  Pilar Carrasco-Garrido; Ana López de Andrés; Valentin Hernández Barrera; Isabel Jiménez-Trujillo; Rodrigo Jiménez-García
Journal:  Eur J Public Health       Date:  2010-10-13       Impact factor: 3.367

3.  Migration and health in Italy: a multiethnic adult sample.

Authors:  Emanuela Gualdi-Russo; Alessandro Zironi; Giovanna V Dallari; Stefania Toselli
Journal:  J Travel Med       Date:  2009 Mar-Apr       Impact factor: 8.490

4.  The health of gypsies.

Authors:  M McKee
Journal:  BMJ       Date:  1997-11-08

Review 5.  High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature.

Authors:  Csilla Sipeky; Agnes Weber; Melinda Szabo; Bela I Melegh; Ingrid Janicsek; Greta Tarlos; Istvan Szabo; Katalin Sumegi; Bela Melegh
Journal:  Mol Biol Rep       Date:  2013-05-05       Impact factor: 2.316

6.  Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.

Authors:  D Evans; U Seedorf; F U Beil
Journal:  Clin Genet       Date:  2005-10       Impact factor: 4.438

7.  Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration.

Authors:  H N van der Vliet; M G Sammels; A C Leegwater; J H Levels; P H Reitsma; W Boers; R A Chamuleau
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

8.  Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism.

Authors:  Aivar Lookene; Jennifer A Beckstead; Solveig Nilsson; Gunilla Olivecrona; Robert O Ryan
Journal:  J Biol Chem       Date:  2005-05-06       Impact factor: 5.157

9.  Atherogenicity of triglyceride-rich lipoproteins.

Authors:  R M Krauss
Journal:  Am J Cardiol       Date:  1998-02-26       Impact factor: 2.778

10.  Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians.

Authors:  Péter Kisfali; Márton Mohás; Anita Maasz; Ferenc Hadarits; Lajos Markó; Katalin Horvatovich; Tamás Oroszlán; Zoltán Bagosi; Zoltán Bujtor; Beáta Gasztonyi; István Wittmann; Béla Melegh
Journal:  Circ J       Date:  2008-01       Impact factor: 2.993

View more
  2 in total

1.  Sequence Analysis of APOA5 Among the Kuwaiti Population Identifies Association of rs2072560, rs2266788, and rs662799 With TG and VLDL Levels.

Authors:  Anfal A Jasim; Suzanne A Al-Bustan; Wafa Al-Kandari; Ahmad Al-Serri; Huda AlAskar
Journal:  Front Genet       Date:  2018-04-09       Impact factor: 4.599

2.  Association of rs662799 variant and APOA5 gene haplotypes with metabolic syndrome and its components: a meta-analysis in North Africa.

Authors:  Meriem Hechmi; Hamza Dallali; Meriem Gharbi; Haifa Jmel; Meriem Fassatoui; Yossra Ben Halima; Sonia Bahri; Afaf Bahlous; Abdelmajid Abid; Henda Jamoussi; Abdelhamid Barakat; Rym Kefi
Journal:  Biosci Rep       Date:  2020-08-28       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.